E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer. (2018)
Attributed to:
King's Health Partners Confidence in Concept
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/2159-8290.cd-17-0603
PubMed Identifier: 29610289
Publication URI: http://europepmc.org/abstract/MED/29610289
Type: Journal Article/Review
Volume: 8
Parent Publication: Cancer discovery
Issue: 4
ISSN: 2159-8274